BioElectronics announces distribution agreement with Ream Surgical

NewsGuard 100/100 Score

BioElectronics Corporation has announced that Ream Surgical Ltd. has signed an agreement and issued their initial purchase order for the distribution of ActiPatch in the United Kingdom.

The initial order shipped on July 20th.

Ream Surgical joins the growing list of international distributors for ActiPatch Therapy. BioElectronics has signed agreements in place and shipping has commenced to Germany, Kuwait, Singapore, Turkey, Panama, Canada and Mexico.

"We are pleased to have aligned BioElectronics Corporation with Ream Surgical Ltd. to bring the benefits of ActiPatch healing to the United Kingdom. We have found Ream's staff and management to be both experienced and knowledgeable about the medical device market in the U.K. and look forward to a mutually beneficial relationship for years to come," said Andrew Whelan of BioElectronics.

"Ream Surgical is pleased to be working with BioElectronics to bring the ActiPatch range of products to the U.K. We feel this product will benefit the British public in the overall recovery process and get patients back to normal activities. We look forward to building a close working relationship between the two companies," said Wayne Jarvis of Ream Surgical.

http://www.bioelectronicscorp.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.